Stock listing

Mabion Sa

Selected listing: 272 · MUN · EUR · DE

Mabion Sa (Munich:272), Health Technology. Latest release Aug 26, 2026: Oddifact and Mabion Receive FDA Pre-IND Meeting Grant for RTX-NP (MabionCD20)…

272:MUNEURDEUpdated September 25, 2026

Ticker: Munich:272
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Munich
Currency: EUR

Latest news from Mabion Sa

Oddifact and Mabion Receive FDA Pre-IND Meeting Grant for RTX-NP (MabionCD20) in Immune Thrombocytopenia

August 26, 2026

Mabion S A : Other information to the quarterly report of Mabion S.A. for Q1 2026

May 19, 2026

Mabion S A : Interim condensed financial statements for the 3-month period ended 31 March 2026

May 19, 2026

Mabion S A : Financial statements for the financial year ended 31 December 2025

April 29, 2026

Mabion S A : Presentation of financial results for FY 2025 – Mabion

April 28, 2026

All Mabion Sa news →

Research Mabion Sa

Mabion Sa company profile

View the public company page for Mabion Sa on 6ix.

Mabion Sa news

Read company news and market updates connected to Mabion Sa.

Mabion Sa investor events

Find investor webinars, events, and replay context for Mabion Sa.